Martin Prlic, PhD
Martin Prlic, PhD
Professor
Vaccine and Infectious Disease Division, Fred Hutch
Dr. Martin Prlic studies how the human immune system responds to infections, vaccines and cancer. His team primarily studies T cell and innate-like T-cell responses in mucosal tissues. His lab is particularly interested in understanding how T cells function in inflammatory environments such as infections and cancer. By defining how subsets of T cells regulate their function in health and in various disease states, Dr. Prlic aims to understand how to manipulate these cells for therapeutic use and ultimately improve human health.
Other Appointments & Affiliations
Affiliate Associate Professor, Department of Global Health
University of Washington
Affiliate Associate Professor, Department of Immunology
University of Washington
Faculty Member, Interdisciplinary Program in Pathobiology
University of Washington
Faculty Member, Molecular & Cellular Biology Program
University of Washington & Fred Hutch
Education
PhD., Microbiology, Immunology and Cancer Biology Program, University of Minnesota, 2004
MS, Genetics, University of Salzburg, 1999
Research Interests
Studying T cell, innate-like T cell and NK cell responses in context of infections, vaccines and cancer
Manipulating T cell, innate-like T cell and NK cell responses for therapeutic purposes (incl. infections, vaccines and cancer)
Mucosal immunity
Single-cell analysis approaches
Current Projects
Bystander-activation of memory T cells and subsequent effects on host immunity
Human mucosal-associated invariant T (MAIT) cells in health and disease
Mucosal immunity in response to infections, cancer and other inflammatory diseases
Dr. Prlic in the News
For the Media
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email media@fredhutch.org or call 206.667.2210